Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
Revenue	$ 120,856	$ 63,474
Costs and expenses:
Cost of revenue	15,541	5,441
Research and development:
Noncash compensation	3,331	2,452
Other research and development	43,031	30,270
Total research and development	46,362	32,722
Selling, general and administrative:
Noncash compensation	11,640	6,887
Other selling, general and administrative	38,691	27,694
Total selling, general and administrative	50,331	34,581
Total costs and expenses	112,234	72,744
Operating income (loss)	8,622	(9,270)
Other expense (income):
Interest expense	6,757	2,288
Other income	(3,603)	(880)
Total other expense, net	3,154	1,408
Net income (loss) before taxes	5,468	(10,678)
Income tax expense	408	29
Net income (loss)	$ 5,060	$ (10,707)
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.03	$ (0.07)
Diluted (in dollars per share)	$ 0.03	$ (0.07)
Weighted-average shares of common stock outstanding
Basic (in shares)	146,677,783	146,209,213
Diluted (in shares)	162,769,202	146,209,213
Product [Member]
Revenue:
Revenue	$ 119,655	$ 50,488
License [Member]
Revenue:
Revenue	$ 1,201	$ 12,986